Histocell SL
Derio
About Histocell SL
Histocell SL is a biopharmaceutical company that develops cell therapy products and novel medical devices for regenerative medicine. Histocell works to improve people’s quality of life by creating new Cell Therapy medicaments. Histocell facilities (567 m2) include a 65 m2 GMP-certified manufacturing facility for cell therapy medicinal products, and several laboratories for quality control and R&D activities. Histocell team meets the maximum quality standards through GMP and ISO 9001/2000 certifications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.7M
- Last round: Grant (Feb 2017)
- Website: histocell.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/histocell-sl-121707 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.